Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

GROWING PIPELINE FOR SEPSIS TREATMENTS

Dec. 9, 1991

BIOTECHNICA UPROOTS BIOTECH BUSINESS

Dec. 9, 1991

COURT TO RULE ON MOTION TO BLOCK NICODERM

Dec. 9, 1991

TESTING APPROVAL BUMPS SYNERGEN STOCK

Dec. 9, 1991

APPOINTMENTS AND ADVANCEMENTS

Dec. 9, 1991

BUSH CONSIDERS BIOTECH INITIATIVE

Dec. 6, 1991

ISIS OFFERING FALLS SHORT BY HALF

Dec. 6, 1991

CROWDED MARKET FOR BLOOD CLOT IMAGING

Dec. 6, 1991

ROCHE PAVES WAY FOR CETUS-CHIRON MERGER

Dec. 6, 1991

DENMARK APPROVES CYTOGEN MAb

Dec. 6, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.